BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 33253894)

  • 21. [CME Rheumatology 23: Rheumatoid Arthritis Following COVID-19/SARS-CoV-2 Infection].
    Tamborrini G; Micheroli R
    Praxis (Bern 1994); 2021 Apr; 110(6):293-297. PubMed ID: 33906448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reactivation of SARS-CoV-2 infection following recovery from COVID-19.
    Chen Z; Xie W; Ge Z; Wang Y; Zhao H; Wang J; Xu Y; Zhang W; Song M; Cui S; Wang X; Pan CQ
    J Infect Public Health; 2021 May; 14(5):620-627. PubMed ID: 33848891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No detection of SARS-CoV-2 in cystic fibrosis patients at the Regional (Lazio) Reference Center for CF in Italy.
    Scagnolari C; Bitossi C; Frasca F; Viscido A; Oliveto G; Scordio M; De Vito C; Trancassini M; Midulla F; Cimino G; Pierangeli A; Antonelli G
    J Cyst Fibros; 2020 Sep; 19(5):837-838. PubMed ID: 32593510
    [No Abstract]   [Full Text] [Related]  

  • 24. High prevalence of SARS-CoV-2 infection among symptomatic healthcare workers in a large university tertiary hospital in São Paulo, Brazil.
    Buonafine CP; Paiatto BNM; Leal FB; de Matos SF; de Morais CO; Guerra GG; Martuchelli MVV; Oliveira DBL; Durigon EL; Soares CP; Candido ED; Telezynski BL; Sáfadi MAP; Almeida FJ
    BMC Infect Dis; 2020 Dec; 20(1):917. PubMed ID: 33267836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver fibrosis and adverse outcomes in COVID-19.
    Huang J
    Dig Liver Dis; 2021 Jul; 53(7):799. PubMed ID: 33994131
    [No Abstract]   [Full Text] [Related]  

  • 26. Outcomes of Neonates Born to Mothers With Severe Acute Respiratory Syndrome Coronavirus 2 Infection at a Large Medical Center in New York City.
    Dumitriu D; Emeruwa UN; Hanft E; Liao GV; Ludwig E; Walzer L; Arditi B; Saslaw M; Andrikopoulou M; Scripps T; Baptiste C; Khan A; Breslin N; Rubenstein D; Simpson LL; Kyle MH; Friedman AM; Hirsch DS; Miller RS; Fernández CR; Fuchs KM; Keown MK; Glassman ME; Stephens A; Gupta A; Sultan S; Sibblies C; Whittier S; Abreu W; Akita F; Penn A; D'Alton ME; Orange JS; Goffman D; Saiman L; Stockwell MS; Gyamfi-Bannerman C
    JAMA Pediatr; 2021 Feb; 175(2):157-167. PubMed ID: 33044493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness : A Population-Based Cohort Study.
    Ray JG; Schull MJ; Vermeulen MJ; Park AL
    Ann Intern Med; 2021 Mar; 174(3):308-315. PubMed ID: 33226859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [COVID-toes, a cutaneous sign of innate resistance to SARS-CoV-2].
    Yatim A; Gilliet M
    Rev Med Suisse; 2021 Mar; 17(732):646-652. PubMed ID: 33793103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C.
    Saadoun D; Asselah T; Resche-Rigon M; Charlotte F; Bedossa P; Valla D; Piette JC; Marcellin P; Cacoub P
    Hepatology; 2006 Jun; 43(6):1337-45. PubMed ID: 16729318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detectable Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Human Breast Milk of a Mildly Symptomatic Patient With Coronavirus Disease 2019 (COVID-19).
    Tam PCK; Ly KM; Kernich ML; Spurrier N; Lawrence D; Gordon DL; Tucker EC
    Clin Infect Dis; 2021 Jan; 72(1):128-130. PubMed ID: 32472683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The global impact of SARS-CoV-2 in 181 people with cystic fibrosis.
    McClenaghan E; Cosgriff R; Brownlee K; Ahern S; Burgel PR; Byrnes CA; Colombo C; Corvol H; Cheng SY; Daneau G; Elbert A; Faro A; Goss CH; Gulmans V; Gutierrez H; de Monestrol I; Jung A; Justus LN; Kashirskaya N; Marshall BC; McKone E; Middleton PG; Mondejar-Lopez P; Pastor-Vivero MD; Padoan R; Rizvi S; Ruseckaite R; Salvatore M; Stephenson AL; Filho LVRDS; Melo J; Zampoli M; Carr SB;
    J Cyst Fibros; 2020 Nov; 19(6):868-871. PubMed ID: 33183965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of the combination of modern medicine and traditional Chinese medicine in pulmonary fibrosis arising as a sequelae in convalescent COVID-19 patients: a randomized multicenter trial.
    Lu ZH; Yang CL; Yang GG; Pan WX; Tian LG; Zheng JX; Lv S; Zhang SY; Zheng PY; Zhang SX
    Infect Dis Poverty; 2021 Mar; 10(1):31. PubMed ID: 33731163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune response in SARS-CoV-2 infection: the role of interferons type I and type III.
    Portela Sousa C; Brites C
    Braz J Infect Dis; 2020; 24(5):428-433. PubMed ID: 32866437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on SARS-CoV-2 infection in children.
    Martins MM; Prata-Barbosa A; da Cunha AJLA
    Paediatr Int Child Health; 2021 Feb; 41(1):56-64. PubMed ID: 33616026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistence of intestinal SARS-CoV-2 infection in patients with COVID-19 leads to re-admission after pneumonia resolved.
    Wang X; Zhou Y; Jiang N; Zhou Q; Ma WL
    Int J Infect Dis; 2020 Jun; 95():433-435. PubMed ID: 32353545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1.
    Conti P; Gallenga CE; Tetè G; Caraffa A; Ronconi G; Younes A; Toniato E; Ross R; Kritas SK
    J Biol Regul Homeost Agents; 2020 March-April,; 34(2):333-338. PubMed ID: 32228825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Tropism in the Lungs, Airways, and Vascular Endothelium of Patients With Fatal Coronavirus Disease 2019: An Autopsy Case Series.
    Bhatnagar J; Gary J; Reagan-Steiner S; Estetter LB; Tong S; Tao Y; Denison AM; Lee E; DeLeon-Carnes M; Li Y; Uehara A; Paden CR; Leitgeb B; Uyeki TM; Martines RB; Ritter JM; Paddock CD; Shieh WJ; Zaki SR
    J Infect Dis; 2021 Mar; 223(5):752-764. PubMed ID: 33502471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Search for SARS-CoV-2 RNA in platelets from COVID-19 patients.
    Bury L; Camilloni B; Castronari R; Piselli E; Malvestiti M; Borghi M; KuchiBotla H; Falcinelli E; Petito E; Amato F; Paliani U; Vaudo G; Cerotto V; Gori F; Becattini C; De Robertis E; Lazzarini T; Castaldo G; Mencacci A; Gresele P
    Platelets; 2021 Feb; 32(2):284-287. PubMed ID: 33349108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 seroprevalence in a Belgian cohort of patients with cystic fibrosis.
    Berardis S; Verroken A; Vetillart A; Struyf C; Gilbert M; Gruson D; Gohy S
    J Cyst Fibros; 2020 Nov; 19(6):872-874. PubMed ID: 32828701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.